infectious-diseases

Documents about infectious-diseases

• A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults#350000ClinicalTrials.gov
• Quantitative Constraints on the Condensed-Phase Reaction Rate Constants of Criegee Intermediates with H₂O₂ and H₂O#387573Figshare
• Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment#442634HAL Science
• Optimum temperature and humidity for population growth of <i>Chelifer cancroides</i> that has potential for biocontrol of <i>Varroa destructor</i> in honey bee hives#471725Figshare
• Highly diverse and unknown viruses may enhance Antarctic endoliths’ adaptability#491882eScholarship
• Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells#492118eScholarship
• mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1#609397eScholarship
• Draft genome of the most devastating insect pest of coffee worldwide: the coffee berry borer, Hypothenemus hampei#612017eScholarship
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health#154759ClinicalTrials.gov
• Additional file 1 of Service providers’ perspectives on the quality of care of a new complex psycho-oncological care programme in Germany – mixed methods external evaluation results#241906Figshare
• A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.#390944ClinicalTrials.gov
• Social and Genetic Networks of HIV-1 Transmission in New York City#491877eScholarship
• Investigation on the efficacy of luliconazole-loaded nanostructured lipid carriers for the treatment of skin and nail fungal infection: <i>In-vitro, in-vivo,</i> and <i>ex-vivo</i> characterization#609489Figshare
• Selective restite entrainment and peritectic garnet back-reaction in high-maficity S-type granites (ca. 1770 Ma), southern Aravalli orogen, NW India#205378Figshare
• Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV#283106ClinicalTrials.gov
• Mechanistic insights into the inhibition of biofilm formation and antibacterial action of endophytic <i>Streptomyces</i> strain KJ7TB2 isolated from the Indian Sundarbans Mangrove estuary#342093Figshare
• A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers#349998ClinicalTrials.gov
• Surveillance of Migratory Shorebirds and Seabirds in 2024 in Australia Reveals Incursions of a Diversity of Low Pathogenicity Avian Influenza Viruses, but Not High Pathogenicity Avian Influenza H5N1#361731Figshare
• A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum#363665ClinicalTrials.gov
• Nucleation of Aragonite (CaCO₃) from Monohydrocalcite (CaCO₃.H₂O) Slurries: Kinetics and Activation Energy from Raman Spectroscopy#414743Figshare
• Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals#612078eScholarship
• Comprehensive <i>in vitro</i> antimicrobial and antiviral evaluation, GC- MS profiling, <i>in silico</i> molecular docking and molecular dynamics simulations of <i>Achillea millefolium</i> essential oil#451872Figshare
• Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals#612183eScholarship
• <b>Infection-enriched </b><b><i>Lactobacillus salivarius</i></b><b> and </b><b><i>Lactobacillus reuteri</i></b><b> coordinate type I interferon signaling and intestinal barrier reinforcement against PCV2</b>#456741Figshare
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV#238193ClinicalTrials.gov
• Electronically tuned N-terminal glycine selective bioconjugation enables <i>in vitro </i>and <i>in vivo </i>species-specific <i>Staphylococcus aureus </i>targeting#357094Figshare
• A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells#373662ClinicalTrials.gov
• Successes and final challenges along the HIV care continuum with transwomen in San Francisco#491976eScholarship
• microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2#609464eScholarship
• PATENT PUBLICATION 1242239: A COMPARTMENTAL MODELING APPROACH TO VISCERAL LEISHMANIASIS: TRANSMISSION DYNAMICS, HOST--VECTOR INTERACTIONS, AND CONTROL STRATEGIES#124846DataCite
• PATENT PUBLICATION 1242239: A COMPARTMENTAL MODELING APPROACH TO VISCERAL LEISHMANIASIS: TRANSMISSION DYNAMICS, HOST--VECTOR INTERACTIONS, AND CONTROL STRATEGIES#124847DataCite
• A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)#180206ClinicalTrials.gov
• HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread#609389eScholarship
• Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection#609404eScholarship
• <p>Predicted probability of <i>T</i>. <i>cruzi</i> infection in <i>Rhodnius</i> across a gradient of forest cover (%) at short and long palm-household distances.</p>#195603Figshare
• Disparities in the Quality of Cardiovascular Care Between HIV‐Infected Versus HIV‐Uninfected Adults in the United States: A Cross‐Sectional Study#491825eScholarship
• Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies#491876eScholarship
• Predictors of Injection Cessation and Relapse among Female Sex Workers who Inject Drugs in Two Mexican-US Border Cities#612099eScholarship
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV#158056ClinicalTrials.gov
• B Cell Receptor’s function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism#609439eScholarship
• Economic compensation interventions to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review and meta-analysis#609393eScholarship
• The Impact of Number of Medications on Falls in Aging Persons with Human Immunodeficiency Virus#492082eScholarship
• Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study#612097eScholarship
• The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons#612100eScholarship
• Additional file 1 of “[I]t will be like a full course meal”: healthcare worker perspectives on strategies to optimize integration of PrEP into medication for opioid use disorder and needle and syringe exchange programs for people who use drugs in Kampala, Uganda#318797Figshare
• <p>Number of triatomines collected per landscape site and year, infection with <i>T</i>. <i>cruzi</i> or <i>T</i>. <i>rangeli</i>, and associated landscape characteristics, Cruzeiro do Sul, Acre state, Brazil.</p>#195601Figshare
• Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5#609403eScholarship
• Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey#491814eScholarship
• Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B#612048eScholarship
• <p>Molecular detection of <i>T. cruzi</i> and <i>T. rangeli</i> and identification of blood meal sources in <i>Rhodnius</i> spp. collected from palm trees across landscape sites in Cruzeiro do Sul, Acre state, Brazil, in 2022 and 2024.</p>#195612Figshare